Abstract
It has previously been shown that rat embryo cells treated in vitro with 3-methylcholanthrene (MCA) elicit antibodies in syngeneic rats which react specifically against established MCA-induced sarcomas. To examine the possibility that clonal amplification of one or a few antigenic, preneoplastic clones is responsible for the previously observed specific antibody responses, MCA-treated rat embryo cells have been subjected to 150 Gy of gamma-irradiation before injection into host animals. The resulting antisera were screened for reactivity against a panel of established syngeneic tumours by membrane immunofluorescence and an isotopic antiglobulin test. A positive reaction was observed between an antiserum pool raised against gamma-irradiated MCA-treated cells and the cells of an immunogenic spontaneous mammary carcinoma. Antiserum to gamma-irradiated control (acetone-treated) cells was negative. Thus gamma-irradiation of carcinogen-treated cells before injection failed to abolish specific antibody responses in immunized rats. To investigate further the relationships between cell-carcinogen interaction, neoantigen induction and malignancy, the cells of a non-immunogenic, spontaneous mammary carcinoma were treated with MCA in vitro, and antisera against treated and untreated cells were tested against a panel of established tumours. A positive membrane-immunofluorescence reaction was obtained with an antiserum to MCA-treated cells, but not to untreated cells against an aminoazodye-induced hepatoma, indicating that the previously non-immunogenic mammary carcinoma cells had acquired new antigenic specificities as a consequence of carcinogen treatment.
Full text
PDF







Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Baldwin R. W., Barker C. R., Embleton M. J., Glaves D., Moore M., Pimm M. V. Demonstration of cell-surface antigens on chemically induced tumors. Ann N Y Acad Sci. 1971 Jun 21;177:268–278. doi: 10.1111/j.1749-6632.1971.tb35056.x. [DOI] [PubMed] [Google Scholar]
- Baldwin R. W., Embleton M. J. Immunology of spontaneously arising rat mammary adenocarcinomas. Int J Cancer. 1969 Jul 15;4(4):430–439. doi: 10.1002/ijc.2910040408. [DOI] [PubMed] [Google Scholar]
- Diamond L., Sardet C., Rothblat G. H. The metabolism of 7,12-dimethylbenz(a)anthracene in cell cultures. Int J Cancer. 1968 Nov 15;3(6):838–849. doi: 10.1002/ijc.2910030617. [DOI] [PubMed] [Google Scholar]
- Embleton M. J., Baldwin R. W. Tumour-related antigen specificities associated with 3-methylcholanthrene-treated rat embryo cells. Int J Cancer. 1979 Jun 15;23(6):840–845. doi: 10.1002/ijc.2910230616. [DOI] [PubMed] [Google Scholar]
- Embleton M. J., Heidelberger C. Antigenicity of clones of mouse prostate cells transformed in vitro. Int J Cancer. 1972 Jan 15;9(1):8–18. doi: 10.1002/ijc.2910090103. [DOI] [PubMed] [Google Scholar]
- Embleton M. J., Heidelberger C. Neoantigens on chemically transformed cloned C3H mouse embryo cells. Cancer Res. 1975 Aug;35(8):2049–2055. [PubMed] [Google Scholar]
- Hewitt H. B., Blake E. R., Walder A. S. A critique of the evidence for active host defence against cancer, based on personal studies of 27 murine tumours of spontaneous origin. Br J Cancer. 1976 Mar;33(3):241–259. doi: 10.1038/bjc.1976.37. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lappé M. A. Tumour specific transplantation antigens: possible origin in pre-malignant lesions. Nature. 1969 Jul 5;223(5201):82–84. doi: 10.1038/223082a0. [DOI] [PubMed] [Google Scholar]
- Mondal S., Embleton M. J., Marquardt H., Heidelberger C. Production of variants of decreased malignancy and antigenicity from clones transformed in vitro by methylcholanthrene. Int J Cancer. 1971 Nov 15;8(3):410–420. doi: 10.1002/ijc.2910080308. [DOI] [PubMed] [Google Scholar]
- Williams A. F., Galfrè G., Milstein C. Analysis of cell surfaces by xenogeneic myeloma-hybrid antibodies: differentiation antigens of rat lymphocytes. Cell. 1977 Nov;12(3):663–673. doi: 10.1016/0092-8674(77)90266-5. [DOI] [PubMed] [Google Scholar]
